How a managed service for colon capsule endoscopy works in an overstretched healthcare system. (4th March 2022)

• Record Type: Journal Article
• Authors: White, Elizabeth; Koulaouzidis, Anastasios; Patience, Lesley; Wenzek, Hagen
• Is Part Of: Scandinavian journal of gastroenterology. Volume 57:Number 3(2022)
• Page Start: 359
• Page End: 363
• Publication Date: 2022-03-04
• Subjects: Diagnostic -- colorectal -- cancer -- post-COVID; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; 616.33
• DOI: 10.1080/00365521.2021.2006299
• Languages: English
• ISSNs: 0036-5521

Abstract

Abstract: Lower gastrointestinal diagnostics have been facing significant capacity constraints, which the COVID-19 pandemic has exacerbated due to significant reductions in endoscopy procedures. Colon Capsule Endoscopy (CCE) provides a safe, viable solution to offset ongoing demand and could be a valuable tool for the recovery of endoscopy services post-COVID. NHS Scotland has already begun a country-wide rollout of CCE as a managed service, and NHS England have committed to a pilot scheme of 11, 000 capsules via hospital-based delivery. Here, we outline a proven method of CCE delivery that ensures the CCE and results are delivered in an efficient, clinically robust manner with high patient acceptability levels through a managed service. Delivering CCE without a managed service is likely to be slower, more costly, and less effective, limiting the many benefits of CCE as an addition to the standard diagnostic pathway for bowel cancer.